AP-007

N/A

Report date: 2023/02/01 18:00:10
NME

Base Information

Drug NameAP-007
Drug Alias Namesustained-release nalmefene formulationAP-007
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOpioid receptors antagonists
TargetsOpioid receptors
Therapy Area/IndicationsOpioid-Related Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAdapt Pharma Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAdapt Pharma Ltd
Inactive CompaniesN/A
Active IndicationsOpioid-Related Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A